New Lake Capital Partners, Inc. NLCP
We take great care to ensure that the data presented and summarized in this overview for NewLake Capital Partners, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NLCP
View all-
Axs Investments LLC Port Chester, NY25.5KShares$491,2600.15% of portfolio
-
Ancora Advisors, LLC Cleveland, OH17.3KShares$332,6400.01% of portfolio
-
Canton Hathaway, LLC2.05KShares$39,4620.01% of portfolio
-
Trivant Custom Portfolio Group, LLC San Diego, CA200Shares$3,8500.0% of portfolio
Latest Institutional Activity in NLCP
Top Purchases
Top Sells
About NLCP
NewLake Capital Partners is a leading provider of real estate capital to state-licensed cannabis operators. Founded in 2019, it is a triple-net lease REIT that acquires industrial and retail properties through sale-leaseback transactions, third-party purchases and build-to-suit projects. Its tenants are some of the leading operators in the U.S. state-licensed cannabis industry and it is a trusted partner for their real estate needs.
Insider Transactions at NLCP
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 18
2024
|
David L. Weinstein Director |
SELL
Open market or private sale
|
Direct |
6,000
-10.04%
|
$114,000
$19.2 P/Share
|
Dec 17
2024
|
David L. Weinstein Director |
SELL
Open market or private sale
|
Direct |
3,856
-6.06%
|
$73,264
$19.44 P/Share
|
Dec 12
2024
|
Dina Rollman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,563
+50.0%
|
$29,697
$19.64 P/Share
|
Oct 15
2024
|
Peter A. Kadens Director |
BUY
Grant, award, or other acquisition
|
Direct |
648
+0.59%
|
$12,312
$19.86 P/Share
|
Aug 22
2024
|
David L. Weinstein Director |
SELL
Open market or private sale
|
Direct |
6,026
-8.63%
|
$120,520
$20.56 P/Share
|
Aug 16
2024
|
David L. Weinstein Director |
SELL
Open market or private sale
|
Direct |
8,650
-11.02%
|
$173,000
$20.43 P/Share
|
Aug 15
2024
|
David L. Weinstein Director |
SELL
Open market or private sale
|
Direct |
7,374
-8.59%
|
$147,480
$20.68 P/Share
|
Aug 14
2024
|
David L. Weinstein Director |
SELL
Open market or private sale
|
Direct |
7,950
-8.47%
|
$159,000
$20.84 P/Share
|
Aug 13
2024
|
David L. Weinstein Director |
SELL
Open market or private sale
|
Direct |
12,516
-11.77%
|
$250,320
$20.43 P/Share
|
Aug 12
2024
|
David L. Weinstein Director |
SELL
Open market or private sale
|
Direct |
11,125
-9.47%
|
$222,500
$20.41 P/Share
|
Jul 15
2024
|
Peter A. Kadens Director |
BUY
Grant, award, or other acquisition
|
Direct |
683
+0.62%
|
$12,294
$18.85 P/Share
|
Jun 12
2024
|
Joyce Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,117
+19.51%
|
$59,223
$19.25 P/Share
|
Jun 12
2024
|
Gordon F Dugan Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,675
+7.8%
|
$88,825
$19.25 P/Share
|
Jun 12
2024
|
David L. Weinstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,117
+2.59%
|
$59,223
$19.25 P/Share
|
Jun 12
2024
|
Peter A. Kadens Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,117
+2.79%
|
$59,223
$19.25 P/Share
|
Jun 12
2024
|
Alan Jeffrey Carr Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,117
+16.71%
|
$59,223
$19.25 P/Share
|
Jun 12
2024
|
Peter Wiser Martay Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,117
+3.41%
|
$59,223
$19.25 P/Share
|
Mar 28
2024
|
Anthony Coniglio President and CEO |
BUY
Open market or private purchase
|
Direct |
350
+0.06%
|
$6,650
$19.22 P/Share
|
Mar 28
2024
|
Gordon F Dugan Director |
BUY
Open market or private purchase
|
Direct |
520
+1.02%
|
$9,880
$19.12 P/Share
|
Mar 20
2024
|
Anthony Coniglio President and CEO |
BUY
Open market or private purchase
|
Direct |
100
+0.02%
|
$1,800
$18.38 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 39.9K shares |
---|---|
Open market or private purchase | 2.21K shares |
Open market or private sale | 87.3K shares |
---|---|
Payment of exercise price or tax liability | 3.12K shares |